Evidence map›Paper›PMID 32799578›Full record

ReviewExpert review of neurotherapeutics2020

Manganese-induced neurodegenerative diseases and possible therapeutic approaches.

Airton C Martins, Priscila Gubert, Gustavo R Villas Boas, Marina Meirelles Paes, Abel Santamaría, Eunsook Lee, Alexey A Tinkov, Aaron B Bowman, Michael Aschner

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of neurotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Airton C MartinsDepartment of Molecular Pharmacology, Albert Einstein College of Medicine , Bronx, NY, USA.
Priscila GubertDepartment of Biochemistry, Laboratory of Immunopathology Keizo Asami, LIKA, Federal, University of Pernambuco , Recife, Brazil.
Gustavo R Villas BoasResearch Group on Development of Pharmaceutical Products (P&DProFar), Center for Biological and Health Sciences, Federal University of Western Bahia , Barreiras, Brazil.
Marina Meirelles PaesResearch Group on Development of Pharmaceutical Products (P&DProFar), Center for Biological and Health Sciences, Federal University of Western Bahia , Barreiras, Brazil.
Abel SantamaríaLaboratorio de Aminoácidos Excitadores, Instituto Nacional de Neurología y Neurocirugía , Mexico City, Mexico.
Eunsook LeeDepartment of Pharmaceutical Sciences, Florida A&M University , Tallahassee, FL, USA.
Alexey A TinkovIM Sechenov First Moscow State Medical University (Sechenov University) , Moscow, Russia.
Aaron B BowmanSchool of Health Sciences, Purdue University , West Lafayette, IN, USA.
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine , Bronx, NY, USA.ORCID 0000-0002-2619-1656
Albert Einstein College of Medicine · USUniversidade Federal do Oeste da Bahia · BRFlorida Agricultural and Mechanical University · USInstituto Nacional de Neurología y Neurocirugía · MXPurdue University West Lafayette · USSechenov University · RUUniversidade Federal de Pernambuco · BR

Funding

Mechanisms of Manganese NeurotoxicityR01ES010563 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 2001 to 2026
$11.9M
Mechanisms of Methylmercury Induced Neuron ToxicityR01ES007331 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 1996 to 2026
$10.6M
Mechanism of manganese-induced impairment of astrocytic glutamate transportersR01ES024756 · NIEHS · MEHARRY MEDICAL COLLEGE · PI LEE, EUN SOOK YU · 2015 to 2019
$1.8M
NIEHS NIH HHS R01 ES007331NIEHS NIH HHS R01 ES010563NIEHS NIH HHS R01 ES024756
6 · The paper itself

Abstract

introductionNeurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis and prion disease represent important public health concerns. Exposure to high levels of  heavy metals such as manganese (Mn) may contribute to their development. AREAS COVERED: In this critical review, we address the role of Mn in the etiology of neurodegenerative diseases and discuss emerging treatments of Mn overload, such as chelation therapy. In addition, we discuss natural and synthetic compounds under development as prospective therapeutics. Moreover, bioinformatic approaches to identify new potential targets and therapeutic substances to reverse the neurodegenerative diseases are discussed. EXPERT OPINION: Here, the authors highlight the importance of better understanding the molecular mechanisms of toxicity associated with neurodegenerative diseases, and the role of Mn in these diseases. Additional emphasis should be directed to the discovery of new agents to treat Mn-induced diseases, since present day chelator therapies have limited bioavailability. Furthermore, the authors encourage the scientific community to develop research using libraries of compounds to screen those compounds that show efficacy in regulating brain Mn levels. In addition, bioinformatics may provide novel insight for pathways and clinical treatments associated with Mn-induced neurodegeneration, leading to a new direction in Mn toxicological research.

Indexed as

HumansManganeseNeurodegenerative DiseasesManganeseAlzheimer’s diseaseamyotrophic lateral sclerosisheavy metalsHuntington’s diseasemanganeseParkinson’s disease

Identifiers

PMID32799578
PMCPMC7657997
OpenAlexW3075968653

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.